公司资料
IQVIA 股价、新闻与催化剂
- 股票代码:
- IQV
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
241.24 USD (+1.94%)
收盘价
最后更新: 2026年8月17日
30.1B USD
市值
股价为何变动
As of Aug 17, 2026, IQV closed up 1.94% at $241.24. No new same-company headline was identified in the current news window.
公司概览
业务概览
IQVIA is a healthcare data, analytics, and contract research company that supports pharmaceutical development and commercialization. It is a critical infrastructure name for the drug-development ecosystem rather than a therapeutic developer.
所在地与行业分类
Headquartered in the United States and listed on NYSE, IQVIA has a global footprint across clinical, commercial, and real-world data services. It sits in healthcare services and research infrastructure.
商业模式特征
The company earns revenue from contract research, data analytics, technology-enabled services, and life sciences consulting. Investors focus on clinical demand, services growth, and the health of biopharma R&D budgets.
生物医药行业定位
IQVIA sits inside the biotech ecosystem as a services and data platform. It is not binary like a drug stock, but it is highly relevant because it benefits from and helps enable drug development activity.
未来催化剂
- IQVIA’s key catalyst is still clinical-outsourcing demand, with bookings, backlog conversion, and AI-enabled service productivity doing most of the work. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。